Fig. 6.

Overexpression of SCARNA12 promoted xenograft tumor growth. a Subcutaneous injection of SW620/LV-NC and SW620/LV-SCARNA12 cells into nude mice for xenograft tumor assay (n = 5, each group). b-c Xenograft tumors weights (b) and volumes growth curve (c) were measured every 4 days. d The expression levels of SCARNA12 in xenograft tumors. e The xenograft tumor tissue sections were stained with H&E, and the expression levels of Ki67 and p-AKT were assessed by IHC staining to determine the ratio of positive cells. The results are presented as the mean ± SD (n = 5). * P < 0.05; *** P < 0.001